Literature DB >> 32944944

Cortex leads the thalamic centromedian nucleus in generalized epileptic discharges in Lennox-Gastaut syndrome.

Linda J Dalic1,2, Aaron E L Warren1,3,4, James C Young3, Wesley Thevathasan1,5,6, Annie Roten2, Kristian J Bulluss5,7,8, John S Archer1,2,3,4.   

Abstract

OBJECTIVE: We aimed to assess the roles of the cortex and thalamus (centromedian nucleus [CM]) during epileptic activity in Lennox-Gastaut syndrome (LGS) patients undergoing deep brain stimulation (DBS) surgery as part of the ESTEL (Electrical Stimulation of the Thalamus for Epilepsy of Lennox-Gastaut Phenotype) trial.
METHODS: Twelve LGS patients (mean age = 26.8 years) underwent bilateral CM-DBS implantation. Intraoperatively, simultaneous electroencephalogram (EEG) was recorded (range = 10-34 minutes) from scalp electrodes and bilateral thalamic DBS electrodes. Temporal onsets of epileptic discharges (generalized paroxysmal fast activity [GPFA] and slow spike-and-wave [SSW]) were manually marked on recordings from scalp (ie, "cortex") and thalamus (ie, CM-DBS electrodes). Phase transfer entropy (PTE) analysis quantified the degree of information transfer from cortex to thalamus within different frequency bands around GPFA events.
RESULTS: GPFA was captured in eight of 12 patients (total event number across patients = 168, cumulative duration = 358 seconds). Eighty-six percent of GPFA events were seen in both scalp and thalamic recordings. In most events (83%), onset occurred first at scalp, with thalamic onset lagging by a median of 98 milliseconds (interquartile range = 78.5 milliseconds). Results for SSW were more variable and seen in 11 of 12 patients; 25.4% of discharges were noted in both scalp and thalamus. Of these, 74.5% occurred first at scalp, with a median lag of 75 milliseconds (interquartile range = 228 milliseconds). One to 0.5 seconds and 0.5-0 seconds before GPFA onset, PTE analysis showed significant energy transfer from scalp to thalamus in the delta (1-3 Hz) frequency band. For alpha (8-12 Hz) and beta (13-30 Hz) frequencies, PTE was greatest 1-0.5 seconds before GPFA onset. SIGNIFICANCE: Epileptic activity is detectable in CM of thalamus, confirming that this nucleus participates in the epileptic network of LGS. Temporal onset of GPFA mostly occurs earlier at the scalp than in the thalamus. This supports our prior EEG-functional magnetic resonance imaging results and provides further evidence for a cortically driven process underlying GPFA in LGS.
© 2020 International League Against Epilepsy.

Entities:  

Keywords:  DBS; GPFA; centromedian nucleus; deep brain stimulation; effective connectivity; generalized paroxysmal fast activity

Year:  2020        PMID: 32944944     DOI: 10.1111/epi.16657

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  3 in total

Review 1.  Contributions of Magnetoencephalography to Understanding Mechanisms of Generalized Epilepsies: Blurring the Boundary Between Focal and Generalized Epilepsies?

Authors:  Thandar Aung; Jeffrey R Tenney; Anto I Bagić
Journal:  Front Neurol       Date:  2022-04-27       Impact factor: 4.086

2.  Ictal Electroencephalographic Characteristics of Nodding Syndrome: A Comparative Case-Series from South Sudan, Tanzania, and Uganda.

Authors:  Rajarshi Mazumder; David Kitara Lagoro; Hiroki Nariai; Alberto Danieli; Dawn Eliashiv; Jerome Engel; Bernardo Dalla Bernardina; Josua Kegele; Holger Lerche; James Sejvar; William Matuja; Erich Schmutzhard; Paolo Bonanni; Gianni De Polo; Thomas Wagner; Andrea Sylvia Winkler
Journal:  Ann Neurol       Date:  2022-05-07       Impact factor: 11.274

3.  Successful Hemispherotomy in a Patient with Encephalopathy with Continuous Spikes and Waves during Sleep Related to Neonatal Thalamic Hemorrhage: A Case Report with Intracranial Electroencephalogram Findings.

Authors:  Shimpei Baba; Tohru Okanishi; Toshiki Nozaki; Naoki Ichikawa; Kazuki Sakakura; Mitsuyo Nishimura; Takahiro Yonekawa; Hideo Enoki; Ayataka Fujimoto
Journal:  Brain Sci       Date:  2021-06-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.